Your browser doesn't support javascript.
loading
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer.
Ciscar, Marina; Trinidad, Eva M; Perez-Chacon, Gema; Alsaleem, Mansour; Jimenez, Maria; Jimenez-Santos, Maria J; Perez-Montoyo, Hector; Sanz-Moreno, Adrian; Vethencourt, Andrea; Toss, Michael; Petit, Anna; Soler-Monso, Maria T; Lopez, Victor; Gomez-Miragaya, Jorge; Gomez-Aleza, Clara; Dobrolecki, Lacey E; Lewis, Michael T; Bruna, Alejandra; Mouron, Silvana; Quintela-Fandino, Miguel; Al-Shahrour, Fatima; Martinez-Aranda, Antonio; Sierra, Angels; Green, Andrew R; Rakha, Emad; Gonzalez-Suarez, Eva.
Afiliación
  • Ciscar M; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Trinidad EM; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Perez-Chacon G; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Alsaleem M; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Jimenez M; Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
  • Jimenez-Santos MJ; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Perez-Montoyo H; Bioinformatics Unit, Structural Biology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Sanz-Moreno A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Vethencourt A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Toss M; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Petit A; Medical Oncology, Breast Unit, Catalan Institute of Oncology (ICO), University Hospital of Bellvitge, Barcelona, Spain.
  • Soler-Monso MT; Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
  • Lopez V; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain.
  • Gomez-Miragaya J; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain.
  • Gomez-Aleza C; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Dobrolecki LE; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Lewis MT; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Bruna A; Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas, USA.
  • Mouron S; Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas, USA.
  • Quintela-Fandino M; Cancer Research UK Cambridge Centre, Cambridge, UK.
  • Al-Shahrour F; Breast Cancer Clinical Research Unit, Clinical Research Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Martinez-Aranda A; Breast Cancer Clinical Research Unit, Clinical Research Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Sierra A; Bioinformatics Unit, Structural Biology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Green AR; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Rakha E; Medical Oncology, Breast Unit, Catalan Institute of Oncology (ICO), University Hospital of Bellvitge, Barcelona, Spain.
  • Gonzalez-Suarez E; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
EMBO Mol Med ; 15(4): e16715, 2023 04 11.
Article en En | MEDLINE | ID: mdl-36880458
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: España